What is APMD's relative strength rating?

Relative strength percentiles for APMD are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is APMD in?

APMD is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is APMD in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). APMD benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is APMD?

APMD currently shows an average true range (ATR%) of 13.3%. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does APMD have a seasonal pattern?

TickerStance computes APMD's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what APMD has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did APMD last report earnings?

No SEC EDGAR filings are linked to APMD in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Free

Power rating ↑RS percentile →

One point among 5,340 · As of Tuesday, August 25, 2026, posted ~17:00 ET

APMD

APMD is not confirmed as a leader. 3m RS is unavailable, Market Stance is 52.9

Apnimed, Inc. Common Stock (APMD) — Stance & relative strength

Healthcare · Pharmaceutical Products

$27.37▲ +6.79% todayUSD · close

▼ Stance 53 · Neutral

APMD$27.37▲ +6.79%

TODAY'S READ · AS OF 2026-08-25

As of 2026-08-25, Apnimed, Inc. Common Stock (APMD) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile —

!ADR%—!A/D—!RVOL—!$ Vol—

Market backdrop

52.9Neutral

Trend30% weight47.0 Breadth30% weight56.3 Leadership20% weight42.0 Macro20% weight60.3 Full stance breakdown →

§ Seasonality

Not enough history to compute monthly seasonality for APMD.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

—

RVOL todayvs 50d avg

—

U/D ratiolast 50 sessions

—

Breakout volbreakout day vs 50d avg

—

50d avg $ volumeliquidity proxy

—

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

—

ATR(14)14-day EMA

$3.65

ATR%ATR as % of close

13.33%

Beta vs SPY90d rolling

—

1-ADR stoprisk from close $27.37

—

Fundamentals · APMD

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

Public attention · APMD

Is the crowd watching?

33/ 100 · vs its own 90-day norm

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out39.8Mshares

Market cap$1.1BSmall Cap

FAQ

Frequently asked questions

What is APMD's relative strength rating?: Relative strength percentiles for APMD are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is APMD in?: APMD is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is APMD in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). APMD benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is APMD?: APMD currently shows an average true range (ATR%) of 13.3%. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does APMD have a seasonal pattern?: TickerStance computes APMD's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what APMD has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did APMD last report earnings?: No SEC EDGAR filings are linked to APMD in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

Apnimed, Inc. Common Stock (APMD) — Stance & relative strength

APMD is not confirmed as a leader. 3m RS is unavailable, Market Stance is 52.9

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

Apnimed, Inc. Common Stock (APMD) — Stance & relative strength

APMD is not confirmed as a leader. 3m RS is unavailable, Market Stance is 52.9

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions